Chrysanthemum petals show promise for protecting eyes, study reveals
Jim Crocker
12th February, 2026
The new yellow Chrysanthemum morifolium cultivar MH1 is visually distinct from the white control cultivar HJ throughout its growth stages (a), a difference attributed to a unique metabolic profile characterized by significantly higher levels of xanthophylls and carotenes (b, c).
Key Findings
- A new chrysanthemum variety, MH1, cultivated in China, shows promise for eye health due to its unique chemical composition
- MH1 flowers contain significantly higher levels of lutein and other xanthophylls compared to a standard variety, HJ, suggesting these compounds are key to its beneficial effects
- Chrysanthemum extract from MH1 effectively prevented cell death and retinopathy in zebrafish models, demonstrating direct protective effects against eye damage
References
Main Study
1) Integrated metabolomics and bioactivity analysis of new chrysanthemum cultivar petals: Insights into eye-protecting agents
Published 9th February, 2026
https://doi.org/10.1371/journal.pone.0340052
Related Studies
2) Hypolipidemic Effects and Preliminary Mechanism of Chrysanthemum Flavonoids, Its Main Components Luteolin and Luteoloside in Hyperlipidemia Rats.
3) Comparison of Chemical Constituents and Pharmacological Effects of Different Varieties of Chrysanthemum Flos in China.
4) Flavonoids and caffeoylquinic acids in Chrysanthemum morifolium Ramat flowers: A potentially rich source of bioactive compounds.



14th April, 2024 | Jenn Hoskins